Aplastic Anemia Frequency and Management in Pediatric Liver Transplantations Due to Non-A-E Hepatitis
Hepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in adolescent men within 1-6 months following hepatitis. Most of HAAA's etiology has non-A-E viral hepatitis. Our retrospective study included pa...
Saved in:
| Published in: | The Turkish journal of gastroenterology Vol. 32; no. 3; p. 313 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Turkey
01.03.2021
|
| Subjects: | |
| ISSN: | 2148-5607, 2148-5607 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Hepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in adolescent men within 1-6 months following hepatitis. Most of HAAA's etiology has non-A-E viral hepatitis.
Our retrospective study included patients with acute fulminant hepatitis who had been treated in Ege University Pediatric Gastroenterology, Hepatology and Nutrition Department and İzmir Kent Hospital Clinical, laboratory, and epidemiological data of the patients were collected from the files.
In this study, 499 children underwent liver transplantation (LT) in two pediatric transplantation centers. Sixty-eight (13.6%) out of 499 patients, underwent liver transplantation due to fulminant hepatic failure (FHF). Therefore, a total of 64 patients (34 girls, 30 boys) with a diagnosis of FHF have included in the study. Thirty-two (50.0%) of 64 FHF were due to non-A-E hepatitis and 4 out of the 64 patients (6.2%) with FHF developed HAAA. All of the patients received prednisolone as immunosuppression treatment after LT. Three patients were also given Tacrolimus and 1 received an additional mycophenolate mofetil. One of the patients was given prednisolone and cyclosporine treatment without tacrolimus. Bone marrow transplantation was performed in 1 patient (25.0%). Two of the patients received immunosuppressive treatment including rabbit-derived anti-thymocyte globulin, cyclosporine, and initially prednisolone.
In children who underwent liver transplantation for non-A-E FHF are at high risk to develop aplastic anemia. The clinicians should be alert after orthotropic liver transplantation patient could develop aplastic anemia and early treatment with immunosuppressive therapies result in a more successful outcome. |
|---|---|
| AbstractList | Hepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in adolescent men within 1-6 months following hepatitis. Most of HAAA's etiology has non-A-E viral hepatitis.BACKGROUNDHepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in adolescent men within 1-6 months following hepatitis. Most of HAAA's etiology has non-A-E viral hepatitis.Our retrospective study included patients with acute fulminant hepatitis who had been treated in Ege University Pediatric Gastroenterology, Hepatology and Nutrition Department and İzmir Kent Hospital Clinical, laboratory, and epidemiological data of the patients were collected from the files.METHODSOur retrospective study included patients with acute fulminant hepatitis who had been treated in Ege University Pediatric Gastroenterology, Hepatology and Nutrition Department and İzmir Kent Hospital Clinical, laboratory, and epidemiological data of the patients were collected from the files.In this study, 499 children underwent liver transplantation (LT) in two pediatric transplantation centers. Sixty-eight (13.6%) out of 499 patients, underwent liver transplantation due to fulminant hepatic failure (FHF). Therefore, a total of 64 patients (34 girls, 30 boys) with a diagnosis of FHF have included in the study. Thirty-two (50.0%) of 64 FHF were due to non-A-E hepatitis and 4 out of the 64 patients (6.2%) with FHF developed HAAA. All of the patients received prednisolone as immunosuppression treatment after LT. Three patients were also given Tacrolimus and 1 received an additional mycophenolate mofetil. One of the patients was given prednisolone and cyclosporine treatment without tacrolimus. Bone marrow transplantation was performed in 1 patient (25.0%). Two of the patients received immunosuppressive treatment including rabbit-derived anti-thymocyte globulin, cyclosporine, and initially prednisolone.RESULTSIn this study, 499 children underwent liver transplantation (LT) in two pediatric transplantation centers. Sixty-eight (13.6%) out of 499 patients, underwent liver transplantation due to fulminant hepatic failure (FHF). Therefore, a total of 64 patients (34 girls, 30 boys) with a diagnosis of FHF have included in the study. Thirty-two (50.0%) of 64 FHF were due to non-A-E hepatitis and 4 out of the 64 patients (6.2%) with FHF developed HAAA. All of the patients received prednisolone as immunosuppression treatment after LT. Three patients were also given Tacrolimus and 1 received an additional mycophenolate mofetil. One of the patients was given prednisolone and cyclosporine treatment without tacrolimus. Bone marrow transplantation was performed in 1 patient (25.0%). Two of the patients received immunosuppressive treatment including rabbit-derived anti-thymocyte globulin, cyclosporine, and initially prednisolone.In children who underwent liver transplantation for non-A-E FHF are at high risk to develop aplastic anemia. The clinicians should be alert after orthotropic liver transplantation patient could develop aplastic anemia and early treatment with immunosuppressive therapies result in a more successful outcome.CONCLUSIONIn children who underwent liver transplantation for non-A-E FHF are at high risk to develop aplastic anemia. The clinicians should be alert after orthotropic liver transplantation patient could develop aplastic anemia and early treatment with immunosuppressive therapies result in a more successful outcome. Hepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in adolescent men within 1-6 months following hepatitis. Most of HAAA's etiology has non-A-E viral hepatitis. Our retrospective study included patients with acute fulminant hepatitis who had been treated in Ege University Pediatric Gastroenterology, Hepatology and Nutrition Department and İzmir Kent Hospital Clinical, laboratory, and epidemiological data of the patients were collected from the files. In this study, 499 children underwent liver transplantation (LT) in two pediatric transplantation centers. Sixty-eight (13.6%) out of 499 patients, underwent liver transplantation due to fulminant hepatic failure (FHF). Therefore, a total of 64 patients (34 girls, 30 boys) with a diagnosis of FHF have included in the study. Thirty-two (50.0%) of 64 FHF were due to non-A-E hepatitis and 4 out of the 64 patients (6.2%) with FHF developed HAAA. All of the patients received prednisolone as immunosuppression treatment after LT. Three patients were also given Tacrolimus and 1 received an additional mycophenolate mofetil. One of the patients was given prednisolone and cyclosporine treatment without tacrolimus. Bone marrow transplantation was performed in 1 patient (25.0%). Two of the patients received immunosuppressive treatment including rabbit-derived anti-thymocyte globulin, cyclosporine, and initially prednisolone. In children who underwent liver transplantation for non-A-E FHF are at high risk to develop aplastic anemia. The clinicians should be alert after orthotropic liver transplantation patient could develop aplastic anemia and early treatment with immunosuppressive therapies result in a more successful outcome. |
| Author | Karaca, Can Özdemir Karadaş, Nihal Yılmaz Karapınar, Deniz Çetin, Funda Aydoğdu, Sema Karakoyun, Miray Hekimci Özdemir, Hamiyet Kıran Taşcı, Ezgi |
| Author_xml | – sequence: 1 givenname: Ezgi surname: Kıran Taşcı fullname: Kıran Taşcı, Ezgi organization: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, İzmir, Turkey – sequence: 2 givenname: Miray surname: Karakoyun fullname: Karakoyun, Miray organization: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, İzmir, Turkey – sequence: 3 givenname: Nihal surname: Özdemir Karadaş fullname: Özdemir Karadaş, Nihal organization: Department of Pediatric Hematology and Oncology, Ege University School of Medicine, İzmir, Turkey – sequence: 4 givenname: Hamiyet surname: Hekimci Özdemir fullname: Hekimci Özdemir, Hamiyet organization: Department of Pediatric Hematology and Oncology, Ege University School of Medicine, İzmir, Turkey – sequence: 5 givenname: Deniz surname: Yılmaz Karapınar fullname: Yılmaz Karapınar, Deniz organization: Department of Pediatric Hematology and Oncology, Ege University School of Medicine, İzmir, Turkey – sequence: 6 givenname: Can surname: Karaca fullname: Karaca, Can organization: Department of Surgery, İzmir Kent Hospital, İzmir, Turkey – sequence: 7 givenname: Funda surname: Çetin fullname: Çetin, Funda organization: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, İzmir, Turkey – sequence: 8 givenname: Sema surname: Aydoğdu fullname: Aydoğdu, Sema organization: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, İzmir, Turkey |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34160361$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkElPwzAQhS1URBe4ckQ-cknxHudYlRaQynIo58i1J5Wrxgmxg9R_TySKxGXeSO-b0cybolFoAiB0S8lcUske0mE_Z4TRoVBJLtCEUaEzqUg--teP0TTGAyFcU8Wu0JgLqghXdIJg0R5NTN7iRYDaG7zu4KuHYE_YBIdfTTB7qCEk7AP-AOdN6gZ447-hw9vOhDjMh2SSb0LEjz3g1OC3JmSLbIWfoR2M5OM1uqzMMcLNWWfoc73aLp-zzfvTy3KxyaxkImUUKsWKStPKUm4d7BwhkgI3BbNW5FwWzBlhdbHjkmmpgAI4bqTLC6FAazZD9797264ZvoiprH20cBxOhKaPJZNCCKlJrgb07oz2uxpc2Xa-Nt2p_IuG_QAhd2d6 |
| CitedBy_id | crossref_primary_10_7759_cureus_29079 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.5152/tjg.2021.20150 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2148-5607 |
| ExternalDocumentID | 34160361 |
| Genre | Journal Article |
| GroupedDBID | 123 2WC 53G AAKDD ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK E3Z EBD ECM EIF EMOBN EOJEC F5P FRP GJB GROUPED_DOAJ HYE IAO IHR INH ITC NPM OBODZ OK1 RPM SV3 SW3 TR2 W2D 7X8 |
| ID | FETCH-LOGICAL-c524t-1ef629f81fc13cdebd0051e3a92cc473592da4c89b352856e1eed3a5d7946e882 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000667494100010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2148-5607 |
| IngestDate | Thu Jul 10 23:24:01 EDT 2025 Thu Jan 02 22:54:33 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c524t-1ef629f81fc13cdebd0051e3a92cc473592da4c89b352856e1eed3a5d7946e882 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/8975469 |
| PMID | 34160361 |
| PQID | 2544458076 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2544458076 pubmed_primary_34160361 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-01 |
| PublicationDateYYYYMMDD | 2021-03-01 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Turkey |
| PublicationPlace_xml | – name: Turkey |
| PublicationTitle | The Turkish journal of gastroenterology |
| PublicationTitleAlternate | Turk J Gastroenterol |
| PublicationYear | 2021 |
| SSID | ssj0038162 |
| Score | 2.1994977 |
| Snippet | Hepatitis-associated aplastic anemia (HAAA) is a rare complication that presented with bone marrow failure after acute hepatitis. HAAA usually occurs in... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 313 |
| SubjectTerms | Adolescent Anemia, Aplastic - epidemiology Anemia, Aplastic - therapy Anemia, Aplastic - virology Child Female Hepatitis, Viral, Human - complications Humans Incidence Liver Transplantation - adverse effects Male Retrospective Studies |
| Title | Aplastic Anemia Frequency and Management in Pediatric Liver Transplantations Due to Non-A-E Hepatitis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34160361 https://www.proquest.com/docview/2544458076 |
| Volume | 32 |
| WOSCitedRecordID | wos000667494100010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEbyG7maTfZykaEsPbelBpbeSTbJS0WzttoL_3pnutj0Jgpe9LAvLZJJ5fF--IeROpJFJU-kxmdmQCa58piRXzItTyaWymbe44f3Sjfr9eDhMBlXDraholcszcXFQm1xjj7yBUlpCxlB2308-GU6NQnS1GqGxSWoBpDJI6YqGKxQBMTFEETg2zSCyR6VoI0Rw3pi9vUJxyLFC9KX3e3q5CDPt_f_-4AHZqxJM2iw94pBsWHdEdnoVhH5MbHMCCTO8pE1nP8aKtqclm_qbKmfomg5Dx46uBnnQLvI3aCmF_q7K-0quoI9zS2c57eeONVmLdiwStGfj4oQ8t1tPDx1WzVpgWnIxY77NQp5ksZ9pP9DGpga3qw1UwrXG8cQJN0roOElRDkaG1ofgGihpUKDeQpp-SrZc7uw5oUpEkLILYzyZiiBD-ZsgkSYQNlNQukd1crs04Ah8GQEK5Ww-L0ZrE9bJWbkKo0kpujGCaBtCtPUv_vD1JdnFtS2pYleklsFOttdkW3-BAaY3CyeBZ3_Q-wGEt8aZ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aplastic+Anemia+Frequency+and+Management+in+Pediatric+Liver+Transplantations+Due+to+Non-A-E+Hepatitis&rft.jtitle=The+Turkish+journal+of+gastroenterology&rft.au=K%C4%B1ran+Ta%C5%9Fc%C4%B1%2C+Ezgi&rft.au=Karakoyun%2C+Miray&rft.au=%C3%96zdemir+Karada%C5%9F%2C+Nihal&rft.au=Hekimci+%C3%96zdemir%2C+Hamiyet&rft.date=2021-03-01&rft.issn=2148-5607&rft.eissn=2148-5607&rft.volume=32&rft.issue=3&rft.spage=313&rft_id=info:doi/10.5152%2Ftjg.2021.20150&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2148-5607&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2148-5607&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2148-5607&client=summon |